#ASCO18 Twitter Highlights June 1 & 2, 2018

What does the first weekend in June mean for oncologists and cancer researchers throughout the world? It means it is time for the  ASCO Annual Meeting in Chicago. I was not able to attend the ASCO Annual Meeting in person this year so I am following the tweets my friends who are attending are sharing.  I was able to take part in a Guideline meeting held at the Meeting on Saturday afterbiib via Webex. So I was there in a sense.
As i the past I will be following the meeting via tweets by doctors , researchers and advocates who are attending. It is not as much fun or exhausting as being there in person but it allows me to keep up to date on the latest results. I'll share the Tweets I found most interesting in the next few blog posts.

I also have been getting e-mail updates from ASCO regarding breaking news and important topics from the meeting. Below the tweets you will find some articles from the ASCO Daily News and ASCO Post that you may find of interest.

First the Tweets:

MATCH TRIAL

MATCH trial results at #ASCO18: sobering reality of precision guided trial enrollment—not always a home run. pic.twitter.com/Pt0XkHSXGj

— Michael Fisch (@fischmd) June 1, 2018

Lynch Syndrome:

Lynch syndrome is common among patient with MSI-high tumors. Via @ASCOPost #ASC018 https://t.co/lJdGKBXvqU pic.twitter.com/bm7JeSxZ7z

— Dr Muin J. Khoury (@MuinJKhoury) June 2, 2018

A genomic study of more than 15,000 #tumor samples presented at #ASCO18 showed that people w/ tumors w/ MSI-H are more likely to have #LynchSyndrome & thus have an increased risk of developing certain types of #cancer . More @ASCOPost https://t.co/lrr0adtMU6 pic.twitter.com/cYQb1yjpKY

— Gil Morgan (@weoncologists) June 2, 2018

Survivorship

Excited to share our survivorship research at #ASCO2018, now published in @JAMAOnc. @AnilSoodMD @MDAndersonNews https://t.co/C0ua5g6rQ4

— Dr. Robert Dood (@DrRobDood) June 2, 2018

Endometrial Cancer

Important finding regarding the importance of weight and #cancer development - High BMI OR gaining large amounts of weight can increase risk of obesity-related cancers like #endometrialcancer #breastcancer #kidneycancer #gyncsm #ASCO18

— Shannon Westin (@ShannonWestin) June 1, 2018

#lcsm #gyncsm #hancsm #asco18 https://t.co/tgyvCJN979

— Danielle Pardue (@Actorielle) June 1, 2018

Clinical Trial Participation:

This highlights one of the many frustrating reasons why clinicians often cannot enroll their patients in #clinicaltrials despite trying, and wanting to! Eligibility criteria need to be more thoughtful, rather than reflexive, standard, or automatic #ASCO18
https://t.co/AL3lbQlmKp

— Thomas LeBlanc, MD (@tomleblancMD) June 2, 2018

ASCO POST or DAILY News Articles:

Lynch Syndrome:
www.ascopost.com/News/58898

Patient Communication:
https://am.asco.org/addressing-patient-communication-challenges

Patient Survivorship Care:
https://am.asco.org/patients-moderate-severe-anxiety-or-depression-symptoms-recognizing-assessing-referring-and

IMPACT Trial :
http://www.ascopost.com/News/58897?email=865aa94a58f0b27b9edd2aa71d80e9a99b924971f7ce90316a0d742b2e9c9b1c

Patient Education and Quality of Care:
https://am.asco.org/patient-education-essential-element-quality-cancer-care
Economics and Value Discussion:
https://am.asco.org/bringing-economics-back-value-discussions

I'm looking forward to the next few days when there will be a greater emphasis on Gynecologic Cancers.

Dee
Every Day is a Blessing!

Ovarian Cancer Screening in Asymptomatic Women - USPSTF

In 2012, I wrote a blog post titled I Agree with the USPSTF  regarding the latest recommendation on screening asymptomatic women for ovarian cancer.

On February 13, 2018 the USPSTK released an updated recommendation.

The USPSTF recommends against screening for ovarian cancer in asymptomatic women.
This recommendation applies to asymptomatic women who are not known to have a high-risk hereditary cancer syndrome.
Grade: D 
(The USPSTF recommends against the service. There is moderate to high certainty the service has no net benefits or the harms outweigh the benefits.)

You can read the full recommendation here.

In the February 25th issue of the ASCO Post. Michael J. Barry, MD said "“Evidence shows that current screening methods do not prevent women from dying of ovarian cancer and that screening can lead to unnecessary surgery in women without cancer.”

Remember if you have a history of breast or ovarian cancer in your family these recommendations do NOT apply to you.

It is sad that in the past six years there is still no effective screening test for ovarian cancer that is both specific and sensitive to the disease. We still have a lot of work to do to help find a test that will find ovarian cancer at an early stage.

Dee
Every Day is a Blessing!

My ASCO Post Interview

Back in January I was interviewed for an article in ASCO Post. I told my story, talked about my experience with my healthcare providers and talked about the importance of research.

Click here to read the interview.

I really appreciate the opportunity to share my story in a publication geared toward oncologists, clinicians and research scientists. Thank you ASCO Post.

Dee
Every Day is A Blessing!